Detection of treatment-induced changes in signaling pathways in gastrointestinal stromal tumors using transcriptomic data

Cancer Research

Volumn 69, Issue 23, 2009, Pages 9125-9132

  Ochs, Michael F ^a   Rink, Lori ^b   Tarn, Chi ^b   Mburu, Sarah ^b   Taguchi, Takahiro ^c   Eisenberg, Burton ^d   Godwin, Andrew K ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c KOCHI UNIVERSITY   (Japan)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; PROTEIN P53; STAT3 PROTEIN; STEM CELL FACTOR; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTOME;

ARTICLE; BAYES THEOREM; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER TISSUE; CELL GROWTH; CELL POPULATION; CONTROLLED STUDY; DNA DAMAGE; DRUG TARGETING; GASTROINTESTINAL STROMAL TUMOR; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; PHARMACOGENETICS; PRIORITY JOURNAL; RNA ANALYSIS; SIGNAL TRANSDUCTION; TISSUE SECTION; TRANSCRIPTION REGULATION; TREATMENT RESPONSE; UPREGULATION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DNA DAMAGE; ETS-DOMAIN PROTEIN ELK-1; GASTROINTESTINAL STROMAL TUMORS; GENE EXPRESSION PROFILING; HUMANS; PIPERAZINES; PYRIMIDINES; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN P53;

EID: 71549130141     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-1709     Document Type: Article

References (50)

1. Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007;26:3291-3310
2. O'Hare T, Eide CA, Deininger MW. New Bcr-Abl inhibitors in chronic myeloid leukemia: keeping resistance in check. Expert Opin Investig Drugs 2008;17:865-878 (Pubitemid 351864324)
3. Corless CL, Heinrich MC. Molecular pathobiology of gastrointestinal stromal sarcomas. Annu Rev Pathol 2008;3:557-586
4. Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 2006;130:1466-1478 (Pubitemid 44520713)
5. Miettinen M, Kopczynski J, Makhlouf HR, et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol 2003;27:625-641 (Pubitemid 36514473)
6. Tworek JA, Goldblum JR, Weiss SW, Greenson JK, Appelman HD. Stromal tumors of the anorectum: a clinicopathologic study of 22 cases. Am J Surg Pathol 1999;23:946-954 (Pubitemid 29360113)
7. Graadt van Roggen JF, van Velthuysen ML, Hogendoorn PC. The histopathological differential diagnosis of gastrointestinal stromal tumours. J Clin Pathol 2001;54:96-102.
8. Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 1983;7:507-519
9. Debiec-Rychter M, Sciot R, Le Cesne A, et al. KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. Eur J Cancer 2006;42:1093-1103 (Pubitemid 44275331)
10. Tarn C, Merkel E, Canutescu AA, et al. Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling. Clin Cancer Res 2005;11:3668-3677 (Pubitemid 40685583)
11. Eisenberg BL, Judson I. Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy. Ann Surg Oncol 2004;11:465-475 (Pubitemid 40486727)
12. Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472-480 (Pubitemid 34879334)
13. Verweij J, Casali PG, Zalcberg J, et al. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet 2004;364:1127-1134 (Pubitemid 39296599)
14. Yeh JJ, Der CJ. Targeting signal transduction in pancreatic cancer treatment. Expert Opin Ther Targets 2007;11:673-694
15. Kanehisa M, Goto S, Kawashima S, Nakaya A. The KEGG databases at GenomeNet. Nucleic Acids Res 2002;30:42-46
16. Liu W, Bagaitkar J, Watabe K. Roles of AKT signal in breast cancer. Front Biosci 2007;12:4011-4019
17. Ochs MF, Stoyanova RS, Arias-Mendoza F, Brown TR. A new method for spectral decomposition using a bilinear Bayesian approach. J Magn Reson 1999;137:161-176 (Pubitemid 129608238)
18. Moloshok TD, Klevecz RR, Grant JD, Manion FJ, Ochs MF. Application of Bayesian decomposition for analysing microarray data. Bioinformatics 2002;18:566-575 (Pubitemid 34521046)
19. Lee DD, Seung HS. Learning the parts of objects by non-negative matrix factorization. Nature 1999;401:788-791 (Pubitemid 129515838)
20. Brunet JP, Tamayo P, Golub TR, Mesirov JP. Metagenes and molecular pattern discovery using matrix factorization. Proc Natl Acad Sci U S A 2004;101:4164-4169 (Pubitemid 38405900)
21. Kim PM, Tidor B. Subsystem identification through dimensionality reduction of large-scale gene expression data. Genome Res 2003;13:1706-1718 (Pubitemid 36874488)
22. West M. Bayesian factor regression models in the "large p, small n" paradigm. In: Bernardo JM, Bayarri MJ, Berger JO, Dawid AP, editors. Bayesian Statistics 7. Oxford: Oxford University Press; 2003.
23. Liao JC, Boscolo R, Yang YL, Tran LM, Sabatti C, Roychowdhury VP. Network component analysis: reconstruction of regulatory signals in biological systems. Proc Natl Acad Sci U S A 2003;100:15522-15527 (Pubitemid 38021022)
24. Draghici S, Khatri P, Bhavsar P, Shah A, Krawetz SA, Tainsky MA. Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate. Nucleic Acids Res 2003;31:3775-3781 (Pubitemid 37442244)
25. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102:15545-15550 (Pubitemid 41528093)
26. Hughes JD, Estep PW, Tavazoie S, Church GM. Computational identification of cis-regulatory elements associated with groups of functionally related genes in Saccharomyces cerevisiae. J Mol Biol 2000;296:1205-1214 (Pubitemid 30695559)
27. Birtwistle MR, Hatakeyama M, Yumoto N, Ogunnaike BA, Hoek JB, Kholodenko BN. Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses. Mol Syst Biol 2007;3:144.
28. Sachs K, Itani S, Carlisle J, Nolan GP, Pe'er D, Lauffenburger DA. Learning signaling network structures with sparsely distributed data. J Comput Biol 2009;16:201-212
29. Mukherjee S, Speed TP. Network inference using informative priors. Proc Natl Acad Sci U S A 2008;105:14313-14318
30. Tebbit C, Zhai J, Untch B, et al. Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care. Breast Cancer Res Treat. Epub 2009 Feb 18.
31. Taguchi T, Sonobe H, Toyonaga S, et al. Conventional and molecular cytogenetic characterization of a new human cell line, GIST-T1, established from gastrointestinal stromal tumor. Lab Invest 2002;82:663-665 (Pubitemid 34522379)
32. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004;5:R80.
33. Wheeler DL, Barrett T, Benson DA, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2008;36:D13-21.
34. Kossenkov A, Manion FJ, Korotkov E, Moloshok TD, Ochs MF. ASAP: automated sequence annotation pipeline for web-based updating of sequence information with a local dynamic database. Bioinformatics 2003;19:675-676 (Pubitemid 36422564)
35. Matys V, Kel-Margoulis OV, Fricke E, et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res 2006;34:D108-10.
36. Ochs MF. Bayesian Decomposition. In: Parmigiani G, Garrett E, Irizarry R, Zeger S, editors. The Analysis of Gene Expression Data: Methods and Software. New York (NY): Springer Verlag; 2003.
37. Gilks WR, Richardson S, Spiegelhalter DJ. Markov chain Monte Carlo in practice. London: Chapman & Hall; 1996.
38. Cangelosi R, Goriely A. Component retention in principal component analysis with application to cDNA microarray data. Biol Direct 2007;2:2. (Pubitemid 46711876)
39. Bidaut G, Manion FJ, Garcia C, Ochs MF. WaveRead: automatic measurement of relative gene expression levels from microarrays using wavelet analysis. J Biomed Inform 2006;39:379-388 (Pubitemid 44038938)
40. Braconi C, Bracci R, Bearzi I, et al. Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients. Ann Oncol 2008;19:1293-1298 (Pubitemid 351911960)
41. Tarn C, Rink L, Merkel E, et al. Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors. Proc Natl Acad Sci U S A 2008;105:8387-8392 (Pubitemid 351904765)
42. Tarn C, Godwin AK. The molecular pathogenesis of gastrointestinal stromal tumors. Clin Colorectal Cancer 2006;6 Suppl 1:S7-17.
43. Eisenberg BL, Harris J, Blanke CD, et al. Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. J Surg Oncol 2009;99:42-47
44. Rink L, Skorobogatko Y, Kossenkov A, et al. Genetic signatures indicate predictable rapid response to imatinib mesylate treatment in gastrointestinal stromal tumors. Mol Cancer Ther 2009;8:2172-2182
45. Bidaut G, Suhre K, Claverie JM, Ochs MF. Determination of strongly overlapping signaling activity from microarray data. BMC Bioinformatics 2006;7:99.
46. Burgering BMT. A brief introduction to FOXOlogy. Oncogene 2008;27:2258.
47. Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13:2498-2504 (Pubitemid 37428274)
48. Zhou J, Wulfkuhle J, Zhang H, et al. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stemlike cells is required for viability and maintenance. Proc Natl Acad Sci U S A 2007;104:16158-16163 (Pubitemid 350099378)
49. Goldstein DM, Gray NS, Zarrinkar PP. High-throughput kinase profiling as a platform for drug discovery. Nat Rev Drug Discov 2008;7:391-7.
50. Hallstrom TC, Mori S, Nevins JR. An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell 2008;13:11-22. (Pubitemid 350309738)